|
Counterfeit brand-name jeans are still viable trousers, but counterfeits of drugs (like Tamiflu) that don't work are a major risk to public health. Human nature got us into this mess: drug developers want their profit, consumers want their wares, and counterfeiters want to make a quick buck any way they can. How do we counter this threat? How do you think we can put the kibosh on the counterfeit drug trade? Is easier testing the tool that the FDA needs, or is political will a bigger issue? Or does the entire pharmaceutical system need an overhaul?
The preceding article is a "sneak peek" from Scientific Instruments, a newsletter from GlobalSpec. To stay up-to-date and informed on industry trends, products, and technologies, subscribe to Scientific Instruments today.
|